References
- Adamson D C, Dawson T M, Zink M C, Clements J E, Dawson V L. Neurovirulent simian immunodeficiency virus infection induces neuronal, endothelial, and glial apoptosis. Mol Med 1996; 2: 417–428, [INFOTRIEVE], [CSA]
- Aksenov M Y, Hasselrot U, Wu G, Nath A, Anderson C, Mactutus C F, Booze R M. Temporal relationships between HIV-1 Tat-induced neuronal degeneration, OX-42 immunoreactivity, reactive astrocytosis, and protein oxidation in the rat striatum. Brain Res 2003; 987: 1–9, [INFOTRIEVE], [CSA], [CROSSREF]
- Arendt G. Neurological manifestations of HIV-infection in the era of highly active antiretroviral therapy (HAART). Fortschr Neurol Psychiatr 2005; 73: 577–586, [INFOTRIEVE], [CSA], [CROSSREF]
- Berger J R, Arendt G. HIV dementia: the role of the basal ganglia and dopaminergic systems. Psychopharmacol 2000; 14: 214–221, [CSA]
- Blanchard-Fillion B, Souza J M, Friel T, Jiang G C, Vrana K, Sharov V, et al. Nitration and inactivation of tyrosine hydroxylase by peroxynitrite. J Biol Chem 2001; 279: 46017–46023, [CSA], [CROSSREF]
- Blennow K, Wallin A, Ekman R. Neuron specific enolase in cerebrospinal fluid: a biochemical marker for neuronal degeneration in dementia disorders?. J Neural Transm Park Dis Dement Sect 1994; 8: 183–91, [INFOTRIEVE], [CSA], [CROSSREF]
- Boven L A, Gomes L, Hery C, Gray F, Verhoef J, Portegies P, et al. Increased peroxynitrite activity in AIDS dementia complex: implications for the neuropathogenesis of HIV-1 infection. J Immunol 1999; 162: 4319–4327, [INFOTRIEVE], [CSA]
- Butterfield D A, Stadtman E R. Protein oxidation processes in aging brain. Adv Cell Aging Gerontol 1997; 2: 161–191, [CSA]
- Dewhurst S, Gelbard H A, Fine S M. Neuropathogenesis of AIDS. Mol Med Today 1996; 2: 16–23, [INFOTRIEVE], [CSA], [CROSSREF]
- Ding M, Haglid K G, Hamberger A. Quantitative immunochemistry on neuronal loss, reactive gliosis and BBB damage in cortex/striatum and hippocampus/amygdale after systemic kainic acid administration. Neurochem Int 2000; 36: 313–318, [INFOTRIEVE], [CSA], [CROSSREF]
- Epstein L G. HIV neuropathogenesis and therapeutic strategies. Acta Paediatr Jpn 1998; 40: 107–111, [INFOTRIEVE], [CSA]
- Hudson L, Liu J, Nath A, Jones M, Raghavan R, Narayan O, et al. Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues. J NeuroVirol 2000; 6: 145–155, [INFOTRIEVE], [CSA]
- Itoh K, Mehraein P, Weis S. Neuronal damage of the substantia nigra in HIV-1 infected brains. Acta Neuropathol (Berl) 2000; 99: 376–384, [CSA], [CROSSREF]
- Jones M V, Bell J E, Nath A. Immunolocalization of HIV envelope gp120 in HIV encephalitis with dementia. AIDS 2000; 14: 2709–2713, [INFOTRIEVE], [CSA], [CROSSREF]
- Koutsiliery E, Sopper S, Scheller C, ter Meulen V, Riederer P. Involvement of dopamine in the progression of AIDS dementia complex. J Neural Transm 2002; 109: 399–410, [CSA], [CROSSREF]
- Kumer S C, Vrana K E. Intricate regulation of tyrosine hydroxylase activity and gene expression. J Neurochem 1996; 67: 443–462, [INFOTRIEVE], [CSA]
- Li L -B, Chen N, Ramamoorthy S, Chi L, Cui X -N, Wang L C, et al. The role of N-glycosylation in function and surface trafficking of the human dopamine transporter. J Biol Chem 2004; 279: 21012–21020, [INFOTRIEVE], [CSA], [CROSSREF]
- Manji H, Miller R. Neurology of HIV infection. J Neurol Neurosurg Psychiatry 2004; 75: 29–35, [CSA], [CROSSREF]
- Mash D C, Pablo J, Ouyang Q, Hearn W L, Izenwasser S. Dopamine transport function is elevated in cocaine users. J Neurochem 2002; 81: 292–300, [INFOTRIEVE], [CSA], [CROSSREF]
- Miller G W, Staley J K, Heilman C J, Perez J T, Mash D C, Rye D B, et al. Immunochemical analysis of dopamine transporter protein in Parkinson's disease. Ann Neurology 1997; 41: 530–539, [CSA], [CROSSREF]
- Nath A, Anderson C, Jones M, Maragos W, Booze R, Mactutus C, et al. Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia. J Psychopharmacol 2000; 14: 222–227, [INFOTRIEVE], [CSA]
- Nath A, Hauser K F, Wojna V, Booze R M, Maragos W, Prendergast M, et al. Molecular basis for interactions of HIV and drugs of abuse. J Acquir Immune Defic Syndr 2002; 31: S62–S69, [INFOTRIEVE], [CSA]
- Navia B A, Cho E S, Petito C K, Price R W. The AIDS dementia complex. II. Neuropathology. Ann Neurol 1986; 19: 525–535, [INFOTRIEVE], [CSA], [CROSSREF]
- Reyes M G, Faraldi F, Senseng C S, Flowers C, Fariello R. Nigral degeneration in acquired immune deficiency syndrome (AIDS). Acta Neuropathol (Berl) 1991; 82: 39–44, [CSA], [CROSSREF]
- Saito Y, Sharer L R, Epstein L G, Michaels J, Mintz M, Louder M, et al. Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues. Neurology 1994; 44: 474–481, [INFOTRIEVE], [CSA]
- Wallace D R, Dodson S, Nath A, Booze R M. Estrogen attenuates gp120- and tat(1-72)-induced oxidative stress and prevents loss of dopamine transporter function. Synapse 2005; 59: 51–60, [CSA], [CROSSREF]
- Wang J -G, Chang L, Volkow N, Telang F, Logan J, Ernst T, et al. Decreased brain dopaminergic transporters in HIV-associated dementia patients. Brain 2004; 127: 2452–2458, [INFOTRIEVE], [CSA], [CROSSREF]
- Zauli G, Secchierro P, Rodella L, Gibellini D, Mirandola P, Mazzoni M, et al. HIV-1 Tat-mediated inhibition of the tyrosine hydroxylase gene expression in dopaminergic neuronal cells. J Biol Chem 2000; 275: 4159–4165, [INFOTRIEVE], [CSA], [CROSSREF]